Back To Search Instructions
Protocols
21 protocols meet the specified criteria
Disease Site: Breast - Female
Protocol No.TitleStatus
1200000080NSAID Effects on Clinical and Imaging Breast BiomarkersOpen
1200000123The Sounds of Compassion: Testing How Specific Elements of Meditation Change Daily LifeOpen
1200000138Biospecimen Repository for Individuals at High Risk for Breast, Ovarian, or Other Hereditary CancersOpen
1300000027S1207: Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. e3 Breast Cancer Study- evaluating everolimus with endocrine therapyOpen
1300000153Investigating DNA repair mechanisms, hypoxia and hypoxia signaling pathway markers in breast cancer patientsOpen
1300000477A Single-arm Phase II Trial to Evaluate Serum Estradiol Levels in Patients with Breast Cancer Treated with Vaginal Estrogen, EstringOpen
1300000596Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer RiskOpen
1300000688A retrospective review of patients receiving concurrent capecitabine and radiation therapy for high risk breast cancerOpen
1300000710A single arm Phase II trial to assess association of BRCA1 protein expression with overall response rate in patients with metastatic breast cancer on pegylated liposomal doxorubicinOpen
1312169608Phase II Trial of Metronomic Eribulin (Halaven) In Pretreated Metastatic Breast Cancer (MBC)Open
1402224036A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE) in Patients with Metastatic, GPNMB Over-Expressing, Triple-Negative Breast Cancer Open
1403248464Alliance A011106 ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III StudyOpen
1408438520A011202 A Randomized Phase III Trial Evaluating The Role Of Axillary Lymph Node Dissection In Breast Cancer Patients (Ct1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant ChemotherapyOpen
1408442431A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx System at the Time of Breast Conservation Surgery for Early Stage Breast CancerOpen
1507019170EA1131 A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Observation in Patients with Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant ChemotherapyOpen
1511200024An Open-Label, Single-Arm, Phase II Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Central Nervous System Progression Post-Radiotherapy In Patients With Her2-Positive Metastatic Breast Cancer (Patricia)Open
1604536433A Phase 1/1b, Open-Label, Multicenter, Repeat-Dose, Dose- Selection Study of CPI-444 as Single Agent and in Combination with Atezolizumab in Patients with Selected Incurable CancersOpen
1606619215Genentech PMT4979g: An Open-Label, Phase I/II, Dose Escalation Study Evaluating The Safety And Tolerability Of GDC-0032 In Patients With Locally Advanced Or Metastatic Solid Tumors Or Non-Hodgkin's Lymphoma And In Combination With Endocrine Therapy In Patients With Locally Advanced Or Metastatic Hormone Receptor-Positive Breast CancerOpen
1608779834A FIRST-IN-HUMAN STUDY OF REPEAT DOSING WITH REGN2810, A MONOCLONAL, FULLY HUMAN ANTIBODY TO PROGRAMMED DEATH - 1 (PD-1), AS SINGLE THERAPY AND IN COMBINATION WITH OTHER ANTI-CANCER THERAPIES, IN PATIENTS WITH ADVANCED MALIGNANCIESOpen
1608780514A Randomized, Open-Label, Phase 2 Study of Abemaciclib plus Tamoxifen or Abemaciclib Alone, in Women with Previously Treated Hormone Receptor-Positive, HER2-Negative, Metastatic Breast CancerOpen
PHX-15-0013-10-15S1207: Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. e3 Breast Cancer Study- evaluating everolimus with endocrine therapy Open